Propionic acid in multiple sclerosis: a phase 2b, double-blind, randomized placebo-controlled trial.

Moser T, Hitzl W, Lerda-Casaccia T, Unterhofer M, Demjaha R, Martinez-Serrat M, Khalil M, Harrer A, Böhm B, Hofbauer P, et al.